Tiantan Bio
600161.SS
#3123
Rank
C$6.66 B
Marketcap
C$3.37
Share price
0.59%
Change (1 day)
-16.49%
Change (1 year)

Earnings for Tiantan Bio (600161.SS)

Earnings in 2025 (TTM): C$0.46 Billion

According to Tiantan Bio's latest financial reports the company's current earnings are C$0.87 Billion. In 2024 the company made an earning of C$0.49 Billion, an increase over its 2023 earnings that were of C$0.35 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Tiantan Bio from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.46 B-5.5%
2024 C$0.49 B39.27%
2023 C$0.35 B20.93%
2022 C$0.29 B9%
2021 C$0.26 B19.31%
2020 C$0.22 B7.16%
2019 C$0.20 B15.56%
2018 C$0.18 B-37.89%
2017 C$0.29 B279.1%
2016 C$77.09 M74.12%
2015 C$44.27 M-35.3%
2014 C$68.43 M-44.93%
2013 C$0.12 B25.86%
2012 C$98.74 M33.34%
2011 C$74.05 M32.67%
2010 C$55.82 M-33.91%
2009 C$84.46 M79.09%
2008 C$47.16 M41.34%
2007 C$33.36 M51.9%
2006 C$21.96 M54.4%
2005 C$14.22 M51.32%
2004 C$9.4 M8.94%
2003 C$8.62 M14.06%
2002 C$7.56 M